Lakkis N, Tsyboulev V, Gibson CM, Murphy SA, Weintraub WS, DiBattiste PM, Cannon CP; TACTICS-TIMI-18 Investigators. Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy. Crit Pathw Cardiol. 2002 Dec;1(4):232-7. doi: 10.1097/00132577-200212000-00005.
Scirica BM, Cannon CP, Gibson CM, Murphy SA, Moliterno DJ, Anderson HV, Aguirre FV, Granger CB, Lambrew CT, Rabbani LE, Sapp SK, Booth JE, Ferguson JJ, Braunwald E. Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries. Crit Pathw Cardiol. 2002 Sep;1(3):150-8.
Cannon CP. Palm Pilot programs to improve quality of care in acute coronary syndromes. Crit Pathw Cardiol. 2002 Jun;1(2):113-5. doi: 10.1097/00132577-200206000-00005.
Bahit MC, Murphy SA, Gibson CM, Cannon CP. Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry. Crit Pathw Cardiol. 2002 Jun;1(2):107-12. doi: 10.1097/00132577-200206000-00004.
Cannon CP, Ornato JP. How to develop a critical pathway: the acute coronary syndromes: Acute Cardiac Team to Implement Optimal Treatments Now (ACS ACTION) Program. Crit Pathw Cardiol. 2002 Mar;1(1):53-60.
Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. Crit Pathw Cardiol. 2002 Mar;1(1):44-52. doi: 10.1097/00132577-200203000-00007.
Sharayeva ML, Tcheng JE, Cannon CP. Assessment of compliance with the American College of Cardiology/American Heart Association guidelines for patients with acute coronary syndromes admitted to a tertiary care hospital coronary care unit. Crit Pathw Cardiol. 2002 Mar;1(1):22-5. doi: 10.1097/00132577-200203000-00005.
Cannon CP. Critical pathway for unstable angina and non-ST elevation myocardial infarction: February 2002. Crit Pathw Cardiol. 2002 Mar;1(1):12-21. doi: 10.1097/00132577-200203000-00004.
Cannon CP. Critical Pathways in Cardiology: a journal of evidence-based medicine: translating evidence into practice. Crit Pathw Cardiol. 2002 Mar;1(1):1-2. doi: 10.1097/00132577-200203000-00002.
Lewandrowski K, Chen A, Januzzi J. Cardiac markers for myocardial infarction. A brief review. Am J Clin Pathol. 2002 Dec;118 Suppl:S93-9. doi: 10.1309/3EK7-YVV9-228C-E1XT.
Weber JE, Hollander JE, Murphy SA, Braunwald E, Gibson CM. Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use. J Thromb Thrombolysis. 2002 Dec;14(3):239-45. doi: 10.1023/a:1025056912284.
Gibson CM, de Lemos JA, Murphy SA, Marble SJ, Dauterman KW, Michaels A, Barron HV, Antman EM; TIMI Study Group. Methodologic and clinical validation of the TIMI myocardial perfusion grade in acute myocardial infarction. J Thromb Thrombolysis. 2002 Dec;14(3):233-7. doi: 10.1023/a:1025004911375.
Quatromoni PA, Copenhafer DL, D’Agostino RB, Millen BE. Dietary patterns predict the development of overweight in women: The Framingham Nutrition Studies. J Am Diet Assoc. 2002 Sep;102(9):1239-46. doi: 10.1016/s0002-8223(02)90275-0.
Brassard JA, Curtis BR, Cooper RA, Ferguson J, Komocsar W, Ehardt M, Kupfer S, Maurath C, Swabb E, Cannon CP, Aster RH. Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology. Thromb Haemost. 2002 Dec;88(6):892-7.
Cutlip DE, Chauhan MS, Baim DS, Ho KK, Popma JJ, Carrozza JP, Cohen DJ, Kuntz RE. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 2002 Dec 18;40(12):2082-9. doi: 10.1016/s0735-1097(02)02597-4.
Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP, Braunwald E. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA. 2002 Dec 25;288(24):3124-9. doi: 10.1001/jama.288.24.3124.
Djoussé L, Dorgan JF, Zhang Y, Schatzkin A, Hood M, D’Agostino RB, Copenhafer DL, Kreger BE, Ellison RC. Alcohol consumption and risk of lung cancer: the Framingham Study. J Natl Cancer Inst. 2002 Dec 18;94(24):1877-82. doi: 10.1093/jnci/94.24.1877.
Dixon SR, Whitbourn RJ, Dae MW, Grube E, Sherman W, Schaer GL, Jenkins JS, Baim DS, Gibbons RJ, Kuntz RE, Popma JJ, Nguyen TT, O’Neill WW. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 4;40(11):1928-34. doi: 10.1016/s0735-1097(02)02567-6.
Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D; Framingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002 Dec 10;106(24):3068-72. doi: 10.1161/01.cir.0000039105.49749.6f.
Smith JJ, Henderson JA, Baim DS. The Food and Drug Administration and reprocessing of single-use medical devices: a revised policy and new questions. J Vasc Interv Radiol. 2002 Dec;13(12):1179-82. doi: 10.1016/s1051-0443(07)61962-9.
Turchin A, Kohane IS. Gene homology resources on the World Wide Web. Physiol Genomics. 2002 Dec 3;11(3):165-77. doi: 10.1152/physiolgenomics.00112.2002. Epub 2002 Dec 3.
Millen BE, Quatromoni PA, Nam BH, O’Horo CE, Polak JF, D’Agostino RB. Dietary patterns and the odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Prev Med. 2002 Dec;35(6):540-7. doi: 10.1006/pmed.2002.1116.
Kratz A, Januzzi JL, Lewandrowski KB, Lee-Lewandrowski E. Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromes. Arch Pathol Lab Med. 2002 Dec;126(12):1487-93. doi: 10.1043/0003-9985(2002)126<1487:PPVOAP>2.0.CO;2.
Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E; TACTICS-TIMI 18 Investigators. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol. 2002 Dec 1;90(11):1246-9. doi: 10.1016/s0002-9149(02)02844-8.
Stone GW, Rogers C, Ramee S, White C, Kuntz RE, Popma JJ, George J, Almany S, Bailey S. Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. J Am Coll Cardiol. 2002 Nov 20;40(10):1882-8. doi: 10.1016/s0735-1097(02)02129-0.
Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. J Am Coll Cardiol. 2002 Nov 20;40(10):1761-8. doi: 10.1016/s0735-1097(02)02484-1.
Tofler GH, D’Agostino RB, Jacques PF, Bostom AG, Wilson PW, Lipinska I, Mittleman MA, Selhub J. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk. Thromb Haemost. 2002 Nov;88(5):799-804.
Casserly IP, Aronow HD, Schoenhagen P, Tsutsui H, Popovich J, Goormastic M, Popma JJ, Nissen SE, Tuzcu EM. Relationship between residual atheroma burden and neointimal growth in patients undergoing stenting: analysis of the atherectomy before MULTI-LINK improves lumen gain and clinical outcomes trial intravascular ultrasound substudy. J Am Coll Cardiol. 2002 Nov 6;40(9):1573-8. doi: 10.1016/s0735-1097(02)02341-0.
Sharis PJ, Cannon CP, Rogers WJ, McCabe C, Murphy S, Gibson CM, Stone PH, Braunwald E. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry). Am J Cardiol. 2002 Nov 15;90(10):1154-6. doi: 10.1016/s0002-9149(02)02788-1.
Mauri L, Bonan R, Weiner BH, Legrand V, Bassand JP, Popma JJ, Niemyski P, Prpic R, Ho KK, Chauhan MS, Cutlip DE, Bertrand OF, Kuntz RE. Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. Am J Cardiol. 2002 Nov 15;90(10):1079-83. doi: 10.1016/s0002-9149(02)02773-x.
Cooper HA, de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Gibson CM, Antman EM, Braunwald E. Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration. Am Heart J. 2002 Nov;144(5):790-5. doi: 10.1067/mhj.2002.125618.
Festa A, D’Agostino R Jr, Tracy RP, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med. 2002 Nov;19(11):939-43. doi: 10.1046/j.1464-5491.2002.00824.x.
O’Malley AJ, Normand SL, Kuntz RE. Sample size calculation for a historically controlled clinical trial with adjustment for covariates. J Biopharm Stat. 2002 May;12(2):227-47. doi: 10.1081/bip-120015745.
Baim DS. Epinephrine: a new pharmacologic treatment for no-reflow?. Catheter Cardiovasc Interv. 2002 Nov;57(3):310-1. doi: 10.1002/ccd.10320.
Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002 Oct 31;347(18):1397-402. doi: 10.1056/NEJMoa020265.
Prpic R, Teirstein PS, Reilly JP, Moses JW, Tripuraneni P, Lansky AJ, Giorgianni JA, Jani S, Wong SC, Fish RD, Ellis S, Holmes DR, Kereiakas D, Kuntz RE, Leon MB. Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis. Circulation. 2002 Oct 29;106(18):2340-5. doi: 10.1161/01.cir.0000036366.62288.74.
Pinto DS, Tu TM. Images in clinical medicine. Ventricular septal rupture after myocardial infarction. N Engl J Med. 2002 Oct 24;347(17):1334. doi: 10.1056/NEJMicm020204.
Tarantino V, D’Agostino R, Taborelli G, Melagrana A, Porcu A, Stura M. Acute mastoiditis: a 10 year retrospective study. Int J Pediatr Otorhinolaryngol. 2002 Nov 11;66(2):143-8. doi: 10.1016/s0165-5876(02)00237-9.
Vogel TU, Friedrich TC, O’Connor DH, Rehrauer W, Dodds EJ, Hickman H, Hildebrand W, Sidney J, Sette A, Hughes A, Horton H, Vielhuber K, Rudersdorf R, De Souza IP, Reynolds MR, Allen TM, Wilson N, Watkins DI. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?. J Virol. 2002 Nov;76(22):11623-36. doi: 10.1128/jvi.76.22.11623-11636.2002.
Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, D’Agostino RB, O’Donnell CJ. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1662-7. doi: 10.1161/01.atv.0000034543.78801.69.
Mahoney EM, Jurkovitz CT, Chu H, Becker ER, Culler S, Kosinski AS, Robertson DH, Alexander C, Nag S, Cook JR, Demopoulos LA, DiBattiste PM, Cannon CP, Weintraub WS; TACTICS-TIMI 18 Investigators. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA. 2002 Oct 16;288(15):1851-8. doi: 10.1001/jama.288.15.1851.
Scirica BM, Cannon CP, McCabe CH, Murphy SA, Anderson HV, Rogers WJ, Stone PH, Braunwald E; Thrombolysis in Myocardial Ischemia III Registry Investigators. Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification. Am J Cardiol. 2002 Oct 15;90(8):821-6. doi: 10.1016/s0002-9149(02)02701-7.
Angeja BG, de Lemos J, Murphy SA, Marble SJ, Antman EM, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group. Thrombolysis In Myocardial Infarction. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. Am Heart J. 2002 Oct;144(4):649-56. doi: 10.1067/mhj.2002.124869.
Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K, Murphy S, Gibson CM, Grube E. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheter Cardiovasc Interv. 2002 Oct;57(2):125-34. doi: 10.1002/ccd.10313.
Murphy SA, Chen C, Cannon CP, Antman EM, Gibson CM. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction. Am J Cardiol. 2002 Oct 1;90(7):766-70. doi: 10.1016/s0002-9149(02)02608-5.
Cannon CP; CAPRIE Investigators. Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial). Am J Cardiol. 2002 Oct 1;90(7):760-2. doi: 10.1016/s0002-9149(02)02606-1.
Kannel WB, Wilson PW, Nam BH, D’Agostino RB. Risk stratification of obesity as a coronary risk factor. Am J Cardiol. 2002 Oct 1;90(7):697-701. doi: 10.1016/s0002-9149(02)02592-4.
Atwood LD, Heard-Costa NL, Cupples LA, Jaquish CE, Wilson PW, D’Agostino RB. Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. Am J Hum Genet. 2002 Nov;71(5):1044-50. doi: 10.1086/343822. Epub 2002 Sep 27.
Angeja BG, Kermgard S, Chen MS, McKay M, Murphy SA, Antman EM, Cannon CP, Braunwald E, Gibson CM. The smoker’s paradox: insights from the angiographic substudies of the TIMI trials. J Thromb Thrombolysis. 2002 Jun;13(3):133-9. doi: 10.1023/a:1020470721977.
Milliez P, Richardson AW, Obioha-Ngwu O, Zimetbaum PJ, Papageorgiou P, Josephson ME. Variable electrocardiographic characteristics of isthmus-dependent atrial flutter. J Am Coll Cardiol. 2002 Sep 18;40(6):1125-32. doi: 10.1016/s0735-1097(02)02070-3.
Kleiman NS, Lakkis N, Cannon CP, Murphy SA, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E; TACTICS-TIMI 18 Investigators. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol. 2002 Sep 18;40(6):1044-50. doi: 10.1016/s0735-1097(02)02119-8.
Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PW; Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002 Oct;25(10):1845-50. doi: 10.2337/diacare.25.10.1845.
Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J, Smits PC, van der Giessen WJ, van den Brand M, de Feyter P, Popma JJ. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation. 2002 Sep 24;106(13):1610-3. doi: 10.1161/01.cir.0000034447.02535.d5.
Popma JJ, Kuntz RE, Baim DS. A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease. Circulation. 2002 Sep 24;106(13):1592-4. doi: 10.1161/01.cir.0000033309.35425.a6.
Cannon CP. Evidence-based risk stratification to target therapies in acute coronary syndromes. Circulation. 2002 Sep 24;106(13):1588-91. doi: 10.1161/01.cir.0000030416.80014.f4.
Manning WJ, Zimetbaum PJ. Direct current cardioversion of atrial fibrillation–the next 40 years. Mayo Clin Proc. 2002 Sep;77(9):895-6. doi: 10.4065/77.9.895.
Brener SJ, Murphy SA, Gibson CM, DiBattiste PM, Demopoulos LA, Cannon CP; TACTICS-TIMI 18 Investigators. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombosis in Myocardial Infarction. Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes. Am J Cardiol. 2002 Sep 15;90(6):631-3. doi: 10.1016/s0002-9149(02)02569-9.
Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, Clouse ME, D’Agostino RB, Wilson PW, O’Donnell CJ. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation. 2002 Sep 3;106(10):1189-91. doi: 10.1161/01.cir.0000032135.98011.c4.
Rinfret S, Katsiyiannis PT, Ho KK, Cohen DJ, Baim DS, Carrozza JP, Laham RJ. Effectiveness of rheolytic coronary thrombectomy with the AngioJet catheter. Am J Cardiol. 2002 Sep 1;90(5):470-6. doi: 10.1016/s0002-9149(02)02516-x.
Rinfret S, Cutlip DE, Katsiyiannis PT, Ho KK, Cohen DJ, Carrozza JP Jr, Laham RJ. Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis. Catheter Cardiovasc Interv. 2002 Sep;57(1):24-30. doi: 10.1002/ccd.10275.
Steinbuch M, D’Agostino RB, Mandel JS, Gabrielson E, McClung MR, Stemhagen A, Hofman A. Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study. Regul Toxicol Pharmacol. 2002 Jun;35(3):320-6. doi: 10.1006/rtph.2002.1550.
Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE; Stents And Radiation Therapy (START) Investigators. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002 Aug 27;106(9):1090-6. doi: 10.1161/01.cir.0000027814.96651.72.
Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002 Sep 9;162(16):1867-72. doi: 10.1001/archinte.162.16.1867.
Cohen DJ, Cosgrove RS, Berezin RH, Teirstein PS, Leon MB, Kuntz RE; Gamma-1 Investigators. Cost-effectiveness of gamma radiation for treatment of in-stent restenosis: results from the Gamma-1 trial. Circulation. 2002 Aug 6;106(6):691-7. doi: 10.1161/01.cir.0000023625.12626.29.
Lampert R, Baron SJ, McPherson CA, Lee FA. Heart rate variability during the week of September 11, 2001. JAMA. 2002 Aug 7;288(5):575. doi: 10.1001/jama.288.5.575.
Llewellyn-Thomas HA, Paterson JM, Carter JA, Basinsk A, Myers MG, Hardacre GD, Dunn EV, D’Agostino RB, Wolf PA, Naylor CD. Primary prevention drug therapy: can it meet patients’ requirements for reduced risk?. Med Decis Making. 2002 Jul-Aug;22(4):326-39. doi: 10.1177/0272989X0202200411.
Meigs JB, Larson MG, D’Agostino RB, Levy D, Clouse ME, Nathan DM, Wilson PW, O’Donnell CJ. Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study. Diabetes Care. 2002 Aug;25(8):1313-9. doi: 10.2337/diacare.25.8.1313.
Hanley AJ, Karter AJ, Festa A, D’Agostino R Jr, Wagenknecht LE, Savage P, Tracy RP, Saad MF, Haffner S; Insulin Resistance Atherosclerosis Study. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes. 2002 Aug;51(8):2642-7. doi: 10.2337/diabetes.51.8.2642.
Scirica BM, Cannon CP, Antman EM, Murphy SA, Morrow DA, Sabatine MS, McCabe CH, Gibson CM, Braunwald E. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. Am J Cardiol. 2002 Aug 1;90(3):303-5. doi: 10.1016/s0002-9149(02)02468-2.
Moses JW, Moussa I, Leon MB, Teirstein PS, Fish RD, Ellis SG, Nawas D, Kluck B, Giorgianni JA, Donohoe D, Kuntz RE. Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial). Am J Cardiol. 2002 Aug 1;90(3):243-7. doi: 10.1016/s0002-9149(02)02462-1.
de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Sabatine MS, Rifai N, McCabe CH, Antman EM, Cannon CP, Braunwald E. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol. 2002 Jul 17;40(2):238-44. doi: 10.1016/s0735-1097(02)01948-4.
Kratz A, Lewandrowski KB, Januzzi JL, Flood JG, Lee-Lewandrowski E. Comparison of cardiac marker concentrations in healthy blood donors and hospital patients without acute coronary syndrome. Am J Cardiol. 2002 Jul 15;90(2):177-8. doi: 10.1016/s0002-9149(02)02447-5.
Wong GC, Morrow DA, Murphy S, Kraimer N, Pai R, James D, Robertson DH, Demopoulos LA, DiBattiste P, Cannon CP, Gibson CM. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation. 2002 Jul 9;106(2):202-7. doi: 10.1161/01.cir.0000021921.14653.28.
Gibson CM, Frisch D, Murphy SA, Gourlay SG, Gibbons R, Baran KW, Nguyen M, Palmeri S, Barron HV; LIMIT Study Group. The relationship of intracoronary stent placement following thrombolytic therapy to tissue level perfusion. J Thromb Thrombolysis. 2002 Apr;13(2):63-8. doi: 10.1023/a:1016253028348.
Gibson CM, Dotani MI, Murphy SA, Marble SJ, Dauterman KW, Michaels AD, Dodge JT Jr; RESTORE Investigators. Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Am Heart J. 2002 Jul;144(1):130-5. doi: 10.1067/mhj.2002.123142.
Murphy SA, Gibson CM, Van de Werf F, McCabe CH, Cannon CP. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I). Am J Cardiol. 2002 Jul 1;90(1):51-4. doi: 10.1016/s0002-9149(02)02387-1.
Shields DC, Fitzgerald AP, O’Neill PA, Muckian C, Kenny D, Moran B, Cannon CP, Byrne CE, Fitzgerald DJ. The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists. Pharmacogenomics J. 2002;2(3):182-90. doi: 10.1038/sj.tpj.6500100.
Reynolds MR, Rinaldi MJ, Pinto DS, Cohen DJ. Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol. 2002 Jul;14(7):364-8.
Cannon CP, Nelson SD, Seeger LL, Eckardt JJ. Clear cell chondrosarcoma mimicking chondroblastoma in a skeletally immature patient. Skeletal Radiol. 2002 Jun;31(6):369-72. doi: 10.1007/s00256-002-0519-7. Epub 2002 May 3.
Van De Werf F, Baim DS. Reperfusion for ST-segment elevation myocardial infarction: an overview of current treatment options. Circulation. 2002 Jun 18;105(24):2813-6. doi: 10.1161/01.cir.0000019762.35104.da.
Antman EM, Cooper HA, Gibson CM, de Lemos JA, McCabe CH, Giugliano RP, Coussement P, Murphy S, Scherer J, Anderson K, Van de Werf F, Braunwald E; Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J. 2002 Jun;23(12):928-33. doi: 10.1053/euhj.2001.2964.
Post MJ, Laham RJ, Kuntz RE, Novicki D, Simons M. The effect of intracoronary fibroblast growth factor-2 on restenosis after primary angioplasty or stent placement in a pig model of atherosclerosis. Clin Cardiol. 2002 Jun;25(6):271-8. doi: 10.1002/clc.4960250606.
Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P, Teirstein PS. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2002 Jun 11;105(23):2737-40. doi: 10.1161/01.cir.0000018126.87045.e0.
Cyrus-David MS, Michielutte R, Paskett ED, D’Agostino R Jr, Goff D. Cervical cancer risk as a predictor of Pap smear use in rural North Carolina. J Rural Health. 2002 Winter;18(1):67-76. doi: 10.1111/j.1748-0361.2002.tb00878.x.
Michaels AD, Appleby M, Otten MH, Dauterman K, Ports TA, Chou TM, Gibson CM. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol. 2002 Jun;14(6):299-302.
Cannon CP, Hand MH, Bahr R, Boden WE, Christenson R, Gibler WB, Eagle K, Lambrew CT, Lee TH, MacLeod B, Ornato JP, Selker HP, Steele P, Zalenski RJ; National Heart Attack Alert Program (NHAAP) Coordinating Committee Critical Pathways Writing Group. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. Am Heart J. 2002 May;143(5):777-89. doi: 10.1067/mhj.2002.120260.
Cannon CP, Baim DS. Expanding the reach of primary percutaneous coronary intervention for the treatment of acute myocardial infarction. J Am Coll Cardiol. 2002 Jun 5;39(11):1720-2. doi: 10.1016/s0735-1097(02)01866-1.
Cannon CP. Oral glycoprotein IIb/IIIa inhibition–great idea, but it didn’t work. Am J Med. 2002 Jun 1;112(8):673-5. doi: 10.1016/s0002-9343(02)01146-4.
Meigs JB, D’Agostino RB Sr, Nathan DM, Rifai N, Wilson PW; Framingham Offspring Study. Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care. 2002 Jun;25(6):977-83. doi: 10.2337/diacare.25.6.977.
Kloner RA, Poole K, Shook T, Przyklenk K, Perritt K, Cannon CP. Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period. Am J Cardiol. 2002 Jun 1;89(11):1291-3. doi: 10.1016/s0002-9149(02)02328-7.
Januzzi JL Jr, Snapinn SM, DiBattiste PM, Jang IK, Theroux P. Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Circulation. 2002 May 21;105(20):2361-6. doi: 10.1161/01.cir.0000016359.94919.16.
Savage MP, Fischman DL, Schatz RA, Leon MB, Baim DS, Brinker J, Hirshfeld J, Goldberg S; STRESS Investigators. Stent Restensosis Study. Coronary intervention in the diabetic patient: improved outcome following stent implantation compared with balloon angioplasty. Clin Cardiol. 2002 May;25(5):213-7. doi: 10.1002/clc.4950250504.
Angeja BG, Gibson CM, Chin R, Frederick PD, Every NR, Ross AM, Stone GW, Barron HV; Participants in the National Registry of Myocardial Infarction 2-3. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol. 2002 May 15;89(10):1156-61. doi: 10.1016/s0002-9149(02)02296-8.
Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E; TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002 Apr 23;105(16):1909-13. doi: 10.1161/01.cir.0000014683.52177.b5.
Gibson CM, Chen M, Angeja BG, Murphy SA, Marble SJ, Barron HV, Cannon CP; TIMI Study Group. Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery. J Thromb Thrombolysis. 2002 Feb;13(1):9-12. doi: 10.1023/a:1015355722670.
Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002 May 1;39(9):1518-23. doi: 10.1016/s0735-1097(02)01789-8.
Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am. 2002 Mar;86(2):285-96. doi: 10.1016/s0025-7125(03)00087-7.
Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation. 2002 Apr 30;105(17):2012-8. doi: 10.1161/01.cir.0000015982.70785.b7.
Cannon CP. Enoxaparin in ST elevation MI – a bright future. Eur Heart J. 2002 Apr;23(8):591-2. doi: 10.1053/euhj.2002.3185.
Quatromoni PA, Copenhafer DL, Demissie S, D’Agostino RB, O’Horo CE, Nam BH, Millen BE. The internal validity of a dietary pattern analysis. The Framingham Nutrition Studies. J Epidemiol Community Health. 2002 May;56(5):381-8. doi: 10.1136/jech.56.5.381.
Suntharalingam M, Laskey W, Lansky AJ, Waksman R, White L, Teirstien P, Massullo V, Rutherford B, Elman A, Kuntz RE, Popma JJ, Bonan R. Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1075-82. doi: 10.1016/s0360-3016(01)02712-2.
Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002 Apr 16;105(15):1760-3. doi: 10.1161/01.cir.0000015464.18023.0a.
Fukutomi T, Suzuki T, Popma JJ, Hosokawa H, Yokoya K, Inada T, Hayase M, Kondo H, Ito S, Suzuki S, Itoh M. Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention. Circ J. 2002 Apr;66(4):349-56. doi: 10.1253/circj.66.349.
Gates GA, Beiser A, Rees TS, D’Agostino RB, Wolf PA. Central auditory dysfunction may precede the onset of clinical dementia in people with probable Alzheimer’s disease. J Am Geriatr Soc. 2002 Mar;50(3):482-8. doi: 10.1046/j.1532-5415.2002.50114.x.
Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation. 2002 Apr 9;105(14):1642-9. doi: 10.1161/01.cir.0000013402.34759.46.
Djoussé L, Ellison RC, Beiser A, Scaramucci A, D’Agostino RB, Wolf PA. Alcohol consumption and risk of ischemic stroke: The Framingham Study. Stroke. 2002 Apr;33(4):907-12. doi: 10.1161/hs0402.105245.
Hanley AJ, D’Agostino R Jr, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM; Insluin Resistance Atrherosclerosis Study. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes. 2002 Apr;51(4):1263-70. doi: 10.2337/diabetes.51.4.1263.
Festa A, D’Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002 Apr;51(4):1131-7. doi: 10.2337/diabetes.51.4.1131.
Mannam AP, Ho KK, Cultip DE, Carrozza JP, Cohen DJ, Lorell BH, Laham RJ. Safety of subxyphoid pericardial access using a blunt-tip needle. Am J Cardiol. 2002 Apr 1;89(7):891-3. doi: 10.1016/s0002-9149(02)02211-7.
Cannon CP, McCabe CH, Belder R, Breen J, Braunwald E. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial. Am J Cardiol. 2002 Apr 1;89(7):860-1. doi: 10.1016/s0002-9149(02)02201-4.
Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE; Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002 Mar 19;105(11):1285-90.
de Sousa SO, Mesquita RA, Pinto DS Jr, Gutkind S. Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma. J Oral Pathol Med. 2002 Feb;31(2):78-81. doi: 10.1046/j.0904-2512.2001.10012.x.
Van Dyke T, Paquette D, Grossi S, Braman V, Massaro J, D’Agostino R, Dibart S, Friden P. Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis: a phase-2 multi-center study. J Clin Periodontol. 2002 Feb;29(2):168-76. doi: 10.1034/j.1600-051x.2002.290212.x.
Cannon CP. To cath or not to cath? That used to be the question. Am Heart J. 2002 Mar;143(3):377-80. doi: 10.1067/mhj.2002.120971.
Januzzi JL, Sabatine MS, Eagle KA, Evangelista A, Bruckman D, Fattori R, Oh JK, Moore AG, Sechtem U, Llovet A, Gilon D, Pape L, O’Gara PT, Mehta R, Cooper JV, Hagan PG, Armstrong WF, Deeb GM, Suzuki T, Nienaber CA, Isselbacher EM; International Registry of Aortic Dissection Investigators. Iatrogenic aortic dissection. Am J Cardiol. 2002 Mar 1;89(5):623-6. doi: 10.1016/s0002-9149(01)02312-8.
Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002 Feb 27;287(8):1003-10. doi: 10.1001/jama.287.8.1003.
Leebeek FW, Boersma E, Cannon CP, van de Werf FJ, Simoons ML. Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable. Eur Heart J. 2002 Mar;23(6):444-57. doi: 10.1053/euhj.2001.2751.
Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002 Feb 14;346(7):476-83. doi: 10.1056/NEJMoa011613.
Omland T, de Lemos JA, Morrow DA, Antman EM, Cannon CP, Hall C, Braunwald E. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol. 2002 Feb 15;89(4):463-5. doi: 10.1016/s0002-9149(01)02271-8.
Colyer WR Jr, Burket MW, Ansel GM, Ramee SR, Minor RL, Gibson CM, Cooper CJ. Intra-aortic balloon pump placement following aorto-iliac angioplasty and stent placement. Catheter Cardiovasc Interv. 2002 Feb;55(2):163-8. doi: 10.1002/ccd.10003.
Kwok OH, Prpic R, Gaspar J, Mathey DG, Escobar A, Goldar-Najafi A, Reifart N, Ischinger TA, Popma JJ. Angiographic outcome after intracoronary X-Sizer helical atherectomy and thrombectomy: first use in humans. Catheter Cardiovasc Interv. 2002 Feb;55(2):133-9. doi: 10.1002/ccd.10036.
Gibson CM, Caparon MG. Alkaline phosphatase reporter transposon for identification of genes encoding secreted proteins in gram-positive microorganisms. Appl Environ Microbiol. 2002 Feb;68(2):928-32. doi: 10.1128/aem.68.02.928-932.2002.
Kuntz RE, Baim DS, Cohen DJ, Popma JJ, Carrozza JP, Sharma S, McCormick DJ, Schmidt DA, Lansky AJ, Ho KK, Dandreo KJ, Setum CM, Ramee SR. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol. 2002 Feb 1;89(3):326-30. doi: 10.1016/s0002-9149(01)02235-4.
Solomon DH, Ganz DA, Avorn J, Glynn RJ, Knight EL, Gibson CM, Stone PH. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol. 2002 Feb;55(2):121-8. doi: 10.1016/s0895-4356(01)00427-9.
Angeja BG, Gunda M, Murphy SA, Sobel BE, Rundle AC, Syed M, Asfour A, Borzak S, Gourlay SG, Barron HV, Gibbons RJ, Gibson CM. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation. 2002 Jan 22;105(3):282-5. doi: 10.1161/hc0302.103588.
Januzzi JL, Pasternak RC. Depression, Hostility, and Social Isolation in Patients with Coronary Artery Disease. Curr Treat Options Cardiovasc Med. 2002 Feb;4(1):77-85. doi: 10.1007/s11936-002-0028-y.
Gates GA, Mills D, Nam BH, D’Agostino R, Rubel EW. Effects of age on the distortion product otoacoustic emission growth functions. Hear Res. 2002 Jan;163(1-2):53-60. doi: 10.1016/s0378-5955(01)00377-x.
Rodriguez BL, D’Agostino R, Abbott RD, Kagan A, Burchfiel CM, Yano K, Ross GW, Silbershatz H, Higgins MW, Popper J, Wolf PA, Curb JD. Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: A comparison of incidence and risk factor effects. Stroke. 2002 Jan;33(1):230-6. doi: 10.1161/hs0102.101081.
Gibson CM, Murphy SA, Marble SJ, Cohen DJ, Cohen EA, Lui HK, Young J Jr, Kitt MM, Lorenz TJ, Tcheng JE. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy. Am Heart J. 2002 Jan;143(1):106-10. doi: 10.1067/mhj.2002.119618.
Vasan RS, Massaro JM, Wilson PW, Seshadri S, Wolf PA, Levy D, D’Agostino RB; Framingham Heart Study. Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2002 Jan 1;105(1):48-53. doi: 10.1161/hc0102.101774.
Laham RJ, Simons M, Pearlman JD, Ho KK, Baim DS. Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization. J Am Coll Cardiol. 2002 Jan 2;39(1):1-8. doi: 10.1016/s0735-1097(01)01691-6.
Melagrana A, D’Agostino R, Tarantino V, Taborelli G, Calevo MG. Monothermal air caloric test in children. Int J Pediatr Otorhinolaryngol. 2002 Jan 11;62(1):11-5. doi: 10.1016/s0165-5876(01)00571-7.